253 related articles for article (PubMed ID: 9395247)
1. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
[TBL] [Abstract][Full Text] [Related]
2. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
Huynh DP; Pulst SM
Oncogene; 1996 Jul; 13(1):73-84. PubMed ID: 8700556
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
Scoles DR; Huynh DP; Morcos PA; Coulsell ER; Robinson NG; Tamanoi F; Pulst SM
Nat Genet; 1998 Apr; 18(4):354-9. PubMed ID: 9537418
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation.
Fraenzer JT; Pan H; Minimo L; Smith GM; Knauer D; Hung G
Int J Oncol; 2003 Dec; 23(6):1493-500. PubMed ID: 14612918
[TBL] [Abstract][Full Text] [Related]
6. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
7. Frequency and distribution of NF2 mutations in schwannomas.
Jacoby LB; MacCollin M; Barone R; Ramesh V; Gusella JF
Genes Chromosomes Cancer; 1996 Sep; 17(1):45-55. PubMed ID: 8889506
[TBL] [Abstract][Full Text] [Related]
8. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
Shaw RJ; McClatchey AI; Jacks T
Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
[TBL] [Abstract][Full Text] [Related]
9. Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
Johnson KC; Kissil JL; Fry JL; Jacks T
Oncogene; 2002 Sep; 21(39):5990-7. PubMed ID: 12203111
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients.
Rosenbaum C; Kluwe L; Mautner VF; Friedrich RE; Müller HW; Hanemann CO
Neurobiol Dis; 1998 Jul; 5(1):55-64. PubMed ID: 9702788
[TBL] [Abstract][Full Text] [Related]
11. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.
Lutchman M; Rouleau GA
Cancer Res; 1995 Jun; 55(11):2270-4. PubMed ID: 7757975
[TBL] [Abstract][Full Text] [Related]
12. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
13. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
Chen Y; Gutmann DH; Haipek CA; Martinsen BJ; Bronner-Fraser M; Krull CE
Dev Dyn; 2004 Mar; 229(3):541-54. PubMed ID: 14991710
[TBL] [Abstract][Full Text] [Related]
14. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
[TBL] [Abstract][Full Text] [Related]
15. Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells.
Pelton PD; Sherman LS; Rizvi TA; Marchionni MA; Wood P; Friedman RA; Ratner N
Oncogene; 1998 Oct; 17(17):2195-209. PubMed ID: 9811451
[TBL] [Abstract][Full Text] [Related]
16. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
Surace EI; Haipek CA; Gutmann DH
Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
[TBL] [Abstract][Full Text] [Related]
17. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma].
Sanson M
Rev Neurol (Paris); 1996 Jan; 152(1):1-10. PubMed ID: 8729390
[TBL] [Abstract][Full Text] [Related]
18. Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.
Lepont P; Stickney JT; Foster LA; Meng JJ; Hennigan RF; Ip W
Mutat Res; 2008 Jan; 637(1-2):142-51. PubMed ID: 17868749
[TBL] [Abstract][Full Text] [Related]
19. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
Schmucker B; Ballhausen WG; Kressel M
Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
[TBL] [Abstract][Full Text] [Related]
20. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
Bianchi AB; Hara T; Ramesh V; Gao J; Klein-Szanto AJ; Morin F; Menon AG; Trofatter JA; Gusella JF; Seizinger BR
Nat Genet; 1994 Feb; 6(2):185-92. PubMed ID: 8162073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]